TAYLOR SOILEAU: Open Payments
NPI 1902686827 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 38 payments from 14 companies in 2025. Trend: 2023 $46 · 2024 $798 · 2025 $1,370
Food & beverage: $1,370
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 7 | $581 |
| Penumbra, Inc. | 1 | $147 |
| Novartis Pharmaceuticals Corporation | 2 | $135 |
| Boston Scientific Corporation | 6 | $128 |
| SCPHARMACEUTICALS INC. | 4 | $73 |
| ABIOMED | 3 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $54 |
| Novo Nordisk Inc | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: Assure WCD, Indigo System, LEQVIO, FUROSCIX, LifeVest, LUX-Dx Insertable Cardiac Monitor, Kerendia, CARDIOMEMS.
Industry payments across LA — which companies pay providers there.
